Test Details
Methodology
Capillary electrophoresis (CE)
Result Turnaround Time
2 - 5 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Test Includes
Capillary electrophoresis (CE) is performed initially. If an abnormal hemoglobin is detected, appropriate testing will be performed at an additional charge.
Use
Evaluate hemoglobinopathies, hemolytic anemia; diagnose hereditary persistence of fetal hemoglobin; diagnose thalassemia; evaluate sickling hemoglobins
Custom Additional Information
Fetal hemoglobin is formed of two α-chains and two γ-chains. It is the major hemoglobin during fetal life. Hb F levels decrease after birth by about 3% to 4% per week. In two to three weeks, fetal hemoglobin is about 65%. By six months of age, fetal hemoglobin is <2% of the total hemoglobin. See graph. The oxygen dissociation curve of Hb F is shifted to the left as compared with normal Hb A. This may be due to decreased binding of 2,3-DPG by Hb F (γ-chains). This facilitates placental oxygen transfer. With erythroblastosis fetalis and anoxic states of the newborn; however, Hb F is proportionally lower than in a normal newborn. Some 15 inherited abnormalities of γ-chain structure have been described1 but most are without clinical significance (fetal Hb normally forms <2% of total hemoglobin). An exception is Hb F Poole, which has been reported as a cause of hemolytic disease of the newborn.2
Condition | Hb F Value (%) |
---|---|
Anemias | |
Aplastic anemia (both congenital and acquired) | 5−25 |
Pernicious anemia | 2−6 |
Hereditary spherocytosis | 2−5 |
Hereditary elliptocytosis | 2−5 |
Congenital nonspherocytic hemolytic anemia | 3−4 |
Anemia of chronic infection | 2−3 |
Anemia of blood loss | 2−8 |
Erythropoietic porphyria | 2−10 |
Paroxysmal nocturnal hemoglobinuria | 2−25 |
Hemoglobinopathies | |
Unstable hemoglobins | <10 |
Homozygous Hb S disease | <20 |
Hb Lepore trait | <5 |
Hb Kenya trait | 6−13 |
Thalassemias | |
β-thalassemia minor | <5 |
β-thalassemia intermedia | 5−20 |
β-thalassemia major | 30−95 |
α-thalassemia minor | ∼1 |
Hb H disease | 5−15 |
Hemoglobinopathy-thalassemia interactions | |
S/β-thalassemia | 10−30 |
E/β-thalassemia | 10−50 |
C/β-thalassemia | 10−30 |
Hereditary persistence of fetal hemoglobin (HPFH) | |
African-type | |
heterozygous | 15−40 |
homozygous | 100 |
Greek-type | |
heterozygous | 10−20 |
Swiss-type | |
heterozygous | 1−3 |
In the adult, hereditary persistence of fetal hemoglobin (HPFH) of multiple varieties is associated with varying elevations of Hb F. The homozygous form of HPFH is found only in black individuals. In the heterozygous state, the Hb F level is 15% to 35% in the black type, and 5% to 20% in the Greek type. Homozygous β-thalassemia is associated with Hb F levels <10% to >90%. About 50% of heterozygotes for β-thalassemia have elevated levels around 2%, rarely >5%. The remainder have normal Hb F. Heterozygous S/β-thalassemia may have Hb F in the 5% to 20% range. With homozygous Hb S disease, the level of Hb F varies from 0% to 20%.3 Other conditions associated with elevated Hb F include various anemias: spherocytosis, Fanconi, acquired aplastic, hemolytic hypoplastics, megaloblastic, myelophthisic, and untreated pernicious anemia; all types of leukemia (especially erythroleukemia and juvenile chronic myelogenous leukemia), multiple myeloma and lymphomas, metastatic disease of the bone marrow; pregnancy; miscellaneous disorders reported include infants small for gestational age, infants with chronic intrauterine anoxia with developmental anomalies; during anticonvulsant drug therapy; diabetes; hyper- and hypothyroidism; and macroglobulin. Elevation of Hb F should, then, raise the question of possible underlying disease.
Specimen Requirements
Specimen
Whole blood
Volume
1 mL
Minimum Volume
0.5 mL (Note: This volume does not allow for repeat testing.)
Container
Lavender-top (EDTA) tube
Collection Instructions
To avoid delays in turnaround time, please submit a separate lavender-top tube for each test requiring a lavender-top.
Stability Requirements
Temperature | Period |
---|---|
Room temperature | 14 days |
Refrigerated | 14 days |
Frozen | 14 days |
Freeze/thaw cycles | Stable x3 |
Reference Range
See table.
Age | Percentage |
---|---|
<7 m | Not established |
7 m to 1 y | 0.1% to 6.8% |
≥2 y | 0.0% to 2.0% |
Storage Instructions
Refrigerate at 2°C to 8°C.
Patient Preparation
Fasting or fluid restriction is not necessary.
Causes for Rejection
Clotted specmen
Footnotes
LOINC® Map
Order Code | Order Code Name | Order Loinc | Result Code | Result Code Name | UofM | Result LOINC |
---|---|---|---|---|---|---|
121072 | Hgb, Fetal, Quant | 121692 | Hgb F | % | 32682-7 | |
121072 | Hgb, Fetal, Quant | 121673 | Reflex to HPLC | N/A | ||
Order Code | 121072 | |||||
Order Code Name | Hgb, Fetal, Quant | |||||
Order Loinc | ||||||
Result Code | 121692 | |||||
Result Code Name | Hgb F | |||||
UofM | % | |||||
Result LOINC | 32682-7 | |||||
Order Code | 121072 | |||||
Order Code Name | Hgb, Fetal, Quant | |||||
Order Loinc | ||||||
Result Code | 121673 | |||||
Result Code Name | Reflex to HPLC | |||||
UofM | ||||||
Result LOINC | N/A |
Order Code | Order Name | Result Code | Result Name | UofM | Result LOINC | |
---|---|---|---|---|---|---|
Reflex 1 | 121672 | Hgb F by HPLC | 121712 | Hgb F | % | 42246-9 |
Reflex 1 | ||||||
Order Code | 121672 | |||||
Order Name | Hgb F by HPLC | |||||
Result Code | 121712 | |||||
Result Name | Hgb F | |||||
UofM | % | |||||
Result LOINC | 42246-9 |